Absci's AI-driven drug discovery platform, its potential, challenges, and strategic partnerships. Read here for an investment analysis of ABSI stock.

Discover how to avoid AI coding tool mistakes and turn them into reliable partners with structured workflows and clear strategies.

In a new paper published in Science, researchers from the company Raina Biosciences have detailed their new AI-based design program, called GEMORNA, which can provide mRNA sequences to be used in a ...